BR112018012095A2 - formas sólidas de compostos substituidos de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina - Google Patents
formas sólidas de compostos substituidos de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-aminaInfo
- Publication number
- BR112018012095A2 BR112018012095A2 BR112018012095A BR112018012095A BR112018012095A2 BR 112018012095 A2 BR112018012095 A2 BR 112018012095A2 BR 112018012095 A BR112018012095 A BR 112018012095A BR 112018012095 A BR112018012095 A BR 112018012095A BR 112018012095 A2 BR112018012095 A2 BR 112018012095A2
- Authority
- BR
- Brazil
- Prior art keywords
- solid forms
- phenylbenzo
- isoquinolin
- dihydro
- substituted
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 2
- IKLWZGVCUZDMEL-UHFFFAOYSA-N 6-phenyl-5,6-dihydrobenzo[f]isoquinolin-2-amine Chemical class C1=NC(N)=CC(C2=CC=CC=C22)=C1CC2C1=CC=CC=C1 IKLWZGVCUZDMEL-UHFFFAOYSA-N 0.000 title 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 abstract 1
- -1 3- (2- (2-methoxyethylamino) ethyl) phenyl Chemical group 0.000 abstract 1
- CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical compound C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562268747P | 2015-12-17 | 2015-12-17 | |
| PCT/US2016/067164 WO2017106642A1 (en) | 2015-12-17 | 2016-12-16 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112018012095A2 true BR112018012095A2 (pt) | 2018-11-27 |
Family
ID=59057612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018012095A BR112018012095A2 (pt) | 2015-12-17 | 2016-12-16 | formas sólidas de compostos substituidos de 5,6-di-hidro-6-fenilbenzo[f]isoquinolin-2-amina |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US9981921B2 (https=) |
| EP (2) | EP3390369B1 (https=) |
| JP (2) | JP2018537499A (https=) |
| KR (1) | KR20180086508A (https=) |
| CN (1) | CN108368061A (https=) |
| AU (2) | AU2016369523B2 (https=) |
| BR (1) | BR112018012095A2 (https=) |
| CA (1) | CA3006081A1 (https=) |
| EA (2) | EA036295B1 (https=) |
| ES (1) | ES2935818T3 (https=) |
| HK (1) | HK1256825A1 (https=) |
| IL (1) | IL259556B2 (https=) |
| MX (2) | MX394320B (https=) |
| NZ (1) | NZ742695A (https=) |
| PH (2) | PH12018501246A1 (https=) |
| SA (1) | SA518391805B1 (https=) |
| SG (1) | SG11201804670PA (https=) |
| TW (2) | TWI796250B (https=) |
| WO (1) | WO2017106642A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201804601TA (en) | 2015-12-17 | 2018-07-30 | Arqule Inc | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| EA036295B1 (ru) * | 2015-12-17 | 2020-10-22 | Аркьюл, Инк. | Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений |
| WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
| JP7641247B2 (ja) | 2022-03-02 | 2025-03-06 | 日立建機株式会社 | 機械の性能診断装置 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US6057329A (en) * | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| KR20070092994A (ko) * | 2003-06-18 | 2007-09-14 | 테바 파마슈티컬 인더스트리즈 리미티드 | 플루바스타틴 나트륨 결정형 ｘｉｖ, ｌｘｘｉｉｉ,ｌｘｘｉｘ, ｌｘｘｘ 및 ｌｘｘｘｖｉｉ, 이의 제조 방법,이를 포함하는 조성물 및 이를 사용하는 방법 |
| EP2079736B1 (en) * | 2006-12-29 | 2017-10-18 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as axl inhibitors |
| TWI461410B (zh) * | 2008-12-30 | 2014-11-21 | Arqule Inc | 經取代之５，６－二氫－６－苯基苯並〔f〕異喹啉－２－胺化合物類 |
| CN103476770B (zh) * | 2010-11-25 | 2017-02-15 | 拉蒂欧制药有限责任公司 | 阿法替尼盐和多晶型物 |
| US8815854B2 (en) * | 2011-06-24 | 2014-08-26 | Arqule, Inc. | Substituted imidazopyridinyl compounds |
| US9802954B2 (en) * | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| JP2014530805A (ja) * | 2011-09-30 | 2014-11-20 | スンシネ ルアケ プハルマ カンパニー リミテッド | アジルサルタンの結晶形並びにその製造及び使用 |
| EA036295B1 (ru) * | 2015-12-17 | 2020-10-22 | Аркьюл, Инк. | Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений |
| SG11201804601TA (en) * | 2015-12-17 | 2018-07-30 | Arqule Inc | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| US9847831B2 (en) | 2016-04-08 | 2017-12-19 | Ciena Corporation | Dual wavelenth optical time domain reflectometer systems and methods embedded in a WDM system |
-
2016
- 2016-12-16 EA EA201891430A patent/EA036295B1/ru unknown
- 2016-12-16 WO PCT/US2016/067164 patent/WO2017106642A1/en not_active Ceased
- 2016-12-16 ES ES16876769T patent/ES2935818T3/es active Active
- 2016-12-16 JP JP2018531388A patent/JP2018537499A/ja active Pending
- 2016-12-16 CN CN201680073181.8A patent/CN108368061A/zh active Pending
- 2016-12-16 EP EP16876769.7A patent/EP3390369B1/en active Active
- 2016-12-16 HK HK18115910.5A patent/HK1256825A1/zh unknown
- 2016-12-16 AU AU2016369523A patent/AU2016369523B2/en not_active Ceased
- 2016-12-16 BR BR112018012095A patent/BR112018012095A2/pt not_active Application Discontinuation
- 2016-12-16 EP EP21216052.7A patent/EP4019499A1/en active Pending
- 2016-12-16 MX MX2021000432A patent/MX394320B/es unknown
- 2016-12-16 MX MX2018007414A patent/MX385671B/es unknown
- 2016-12-16 SG SG11201804670PA patent/SG11201804670PA/en unknown
- 2016-12-16 TW TW111124239A patent/TWI796250B/zh not_active IP Right Cessation
- 2016-12-16 NZ NZ742695A patent/NZ742695A/en not_active IP Right Cessation
- 2016-12-16 CA CA3006081A patent/CA3006081A1/en active Pending
- 2016-12-16 EA EA202091691A patent/EA202091691A1/ru unknown
- 2016-12-16 TW TW105141873A patent/TWI771280B/zh not_active IP Right Cessation
- 2016-12-16 IL IL259556A patent/IL259556B2/en unknown
- 2016-12-16 KR KR1020187020340A patent/KR20180086508A/ko not_active Ceased
- 2016-12-16 US US15/381,414 patent/US9981921B2/en active Active
-
2018
- 2018-04-30 US US15/966,091 patent/US10227311B2/en active Active
- 2018-06-13 SA SA518391805A patent/SA518391805B1/ar unknown
- 2018-06-13 PH PH12018501246A patent/PH12018501246A1/en unknown
-
2019
- 2019-01-30 US US16/261,744 patent/US10717710B2/en not_active Expired - Fee Related
-
2020
- 2020-09-14 PH PH12020551465A patent/PH12020551465A1/en unknown
-
2021
- 2021-11-26 JP JP2021191696A patent/JP2022031797A/ja active Pending
-
2022
- 2022-03-21 AU AU2022201947A patent/AU2022201947B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286487A (en) | Technologies useful for oligonucleotide preparation | |
| EA201891024A1 (ru) | Соединения-ингибиторы tank-связывающей киназы | |
| MX2022010755A (es) | Inhibidores de quinasa y usos de los mismos. | |
| WO2017108723A3 (en) | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | |
| IL248546A0 (en) | A polysubstituted fluorine compound as a proton tyrosine kinase inhibitor | |
| EP3181559B8 (en) | 2-(2,4,5-substituted aniline) pyrimidine derivative, pharmaceutical composition and use thereof | |
| CL2016001895A1 (es) | Compuestos | |
| IL271266A (en) | Use of anti cd70 antibody argx-110 to treat acute myeloid leukaemia | |
| MX393838B (es) | Uso de compuestos heterociclicos para controlar nematodos. | |
| NI201800042A (es) | Nuevos derivados de pirrolo[2,3-d]pirimidina como inhibidores duales de dyrk1/clk1 | |
| UY36544A (es) | Derivados de 4h-pirrol[3,2-c]piridin-4-ona | |
| EA201692219A1 (ru) | Способы получения противовирусных соединений | |
| ECSP17030878A (es) | Formas cristalinas de 5-cloro-n4-[2-(dimetilfosforil)fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidina-2,4-diamina | |
| DK3497081T3 (da) | Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte | |
| EP3307738A4 (en) | ARYL-DIHYDRO-2H-BENZO [B] [1,4] OXAZINE-SULPHONAMIDE AND RELATED COMPOUNDS FOR USE AS AGENTS OF RORY AND FOR THE TREATMENT OF DISEASES | |
| UY36737A (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| LT3160958T (lt) | (s)-6-((1-acetilpiperidin-4-il)amino)-n-(3-(3,4-dihidroizochinolin-2(1h)-yl)-2-hidroksipropil)pirimidin-4-karboksamido kristalinės druskos | |
| EP3292119A4 (en) | DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE | |
| UY37517A (es) | Métodos de síntesis de compuestos tiazoles sustituidos | |
| HUE053455T2 (hu) | Eljárás pirrolo[3,2-D]pirimidin vegyület elõállítására és intermedierjei | |
| PH12020551465A1 (en) | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds | |
| EP3448852A4 (en) | NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF TYROSINE KINASE BCR-ABL | |
| BR112016029510A2 (pt) | métodos para a preparação de um composto, e, composto intermediário. | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| DK3624795T3 (da) | Kondenserede, heteroaromatiske anilinforbindelser til behandling af hudforstyrrelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |